SEC Form 4 · accession 0000899243-18-031129
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Charles Robb
Officer — Chief Financial Officer
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 7:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | M | 25,000 | $1.92 | A | 21,858 | D | |
| Common StockF1 | Dec 12, 2018 | S | 25,000 | $19.0061 | D | 6,858 | D | |
| Common StockF2 | holding | — | — | — | 1,568 | I | Custodial account for child | |
| Common StockF2 | holding | — | — | — | 1,568 | I | Custodial account for child | |
| Common StockF2 | holding | — | — | — | 1,568 | I | Custodial account for child |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.92 | Dec 12, 2018 | M | 25,000 | D | — | Nov 19, 2023 | Common Stock | 25,000 | 75,000 | D |
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F2These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.
- F3Fully exercisable.